At a glance
- Originator Eli Lilly and Company
- Class Neuroprotectants; Oxazoles
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Brain injuries; Stroke
Most Recent Events
- 29 Jun 2000 New profile
- 29 Jun 2000 Preclinical development for Brain injuries in USA (Unknown route)
- 29 Jun 2000 Preclinical development for Stroke in USA (Unknown route)